What is Afqlir 40 mg/ml, injection solution used for?

( ARTG ) AFQLIR (aflibercept) 2 mg is indicated in adults for the treatment of:, neovascular (wet) age-related macular degeneration (wet AMD), visual impairment due to macular oedema secondary to central retinal vein occlusion (CRVO), visual impairment due to macular oedema secondary to branch retinal vein occlusion (BRVO), diabetic macular oedema (DME), visual impairment due to myopic choroidal neovascularisation (myopic CNV).

What are the side effects of Afqlir 40 mg/ml, injection solution?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Afqlir 40 mg/ml, injection solution be used during pregnancy?

( AHT ) For the active ingredient aflibercept You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Afqlir 40 mg/ml, injection solution belong to?

Afqlir 40 mg/ml, injection solution: ATC S01LA05. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Afqlir 40 mg/ml, injection solution

INN: X

Data updated: 2026-04-11

Available in:

🇨🇿🇩🇪🇬🇧🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Sandoz Pharmaceuticals AG

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.